Cancer risk associated with simian virus 40 contaminated polio vaccine

Anticancer Research

Volumn 19, Issue 3 B, 1999, Pages 2173-2180

  Fisher, Susan Gross ^a   Weber, Laura ^a   Carbone, Michele ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cancer risk; Polio vaccine; Simian virus 40

Indexed keywords

POLIOMYELITIS VACCINE;

ARTICLE; BONE TUMOR; BRAIN TUMOR; CANCER INCIDENCE; CANCER RISK; CARCINOGENESIS; CELL CULTURE; CHOROID PLEXUS TUMOR; DRUG CONTAMINATION; EPENDYMOMA; HUMAN; MESOTHELIOMA; MONKEY; PRIORITY JOURNAL; SIMIAN VIRUS 40; UNITED STATES;

AGE FACTORS; BONE NEOPLASMS; BRAIN NEOPLASMS; CHOROID PLEXUS NEOPLASMS; COHORT STUDIES; DATABASES, FACTUAL; DRUG CONTAMINATION; EPENDYMOMA; HUMANS; INCIDENCE; MESOTHELIOMA; NATIONAL INSTITUTES OF HEALTH (U.S.); OSTEOSARCOMA; POLIOVIRUS VACCINE, INACTIVATED; RISK ASSESSMENT; RISK FACTORS; SIMIAN VIRUS 40; UNITED STATES;

EID: 0032780697     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Poliomyelitis Surveillance Report No. 248. Communicable Disease Center. Atlanta, Ga., 1962.
2. Eddy BE, Borman GS, Berkeley WH, Young RD: Tumors Induced in hamsters by injection of rhesus monkey kidney cell extracts. Proc Soc Exp Biol Med 107: 191-197, 1961.
3. Eddy BE, Borman GS, Grubbs G, Young RD: Identification of the oncogenic substance in rhesus monkey kidney cell cultures as simian virus 40. Virology 17: 65-75, 1962.
4. Meyers HM Jr, Hopps HE, Rogers NG et al: Studies on Simian virus 40. J Immunol 88: 796-806, 1962.
5. Kirschstein RL, Gerber P: Ependymomas produced after intracerebrai inoculation of SV40 into newborn hamsters. Nature 195: 298-300, 1962.
6. Rabson AS, O'Conor GT, Kirschstein RL, Branigan WJ: Papillary Ependymomas produced in Rattus (Mastomys) Natalensjs inoculated with vacuolating virus (SV40). JNCI 29: 765-787, 1962.
7. Diamandopoulos GT: Induction of lymphocytic leukemia, lymphosarcoma, reticulum cell sarcoma and osteogenic sarcoma in the syrian golden hamster by oncogenic DNA simian virus 40. J Natl Cancer Inst 50: 1347-1365, 1973.
8. Cicala C, Pompetti F, Carbone M: SV40 induces mesotheliomas in hamsters. Am J Pathol 142: 1524-1533, 1993.
9. Melnick JL, Stinbaugh S: Excretion of vacuolating SV40 virus (papovavirus group) after ingestion as a contaminant of oral poliovaccine. Proc Soc Exp Biol Med 109: 965-968, 1962.
10. Morris JA, Johnson KM, Aulisio CG, Chanock RM and Knight V: Clinical and serologic responses in volunteers given vacuolating virus (SV40) by respiratory rout. Proc Soc Exp Biol Med 108: 56-59, 1961.
11. Fraumeni JF, Ederer F, Miller RW: An evaluation of the carcinogenicity of Simian Virus 40 in man. J Amer Med Assoc 185: 713-718, 1963.
12. Mortimer EA Jr, Lepow ML, Gold E, Robbins FC, Burton GJ, Fraumeni JF Jr: Long-term follow-up of persons inadvertently inoculated with SV40 as neonates. N Eng J Med 305: 1517-1518, 1981.
13. Heinonen OP, Shapiro S, Monson RR, Hartz SC, Rosenberg L, Slone D: Immunization during pregnancy against poliomyelitis and influenza in relation to childhood malignancy. Int J Epidemiology 2: 229-234, 1973.
14. Olin P, Giesecke J. Inactivated US polio vaccines used in Sweden during 1957 - No impact in cancer incidence rates 1960-63. Presented @ Workshop - Simian Virus 40 - A possible human polyoma virus. January 1997, Bethesda, Md. (Transcripts available through SAG Corp., Washington, DC, 20008
15. Geiseler E: SV40 and human brain tumors. Prog Med Virol 37: 211-222, 1990.
16. Innis MD: Oncogenesis and poliomyelitis vaccine. Nature 219: 972-973, 1968.
17. Winer L, Herndon R, Narayan O et al: Isolation of virus related to SV40 from patients with progressive multifocal leukoencephaiopathy. N Engl J Med 286: 385-390, 1972.
18. Soriano F, Shelburne CE, Gokcen M. Simian virus 40 in human cancer. Nature 249: 421-424, 1974.
19. Krieg P, Antmann E, Jonas D, et al: Episomal simian virus 40 in human brain tumors. Proc Natl Acad Sci USA 78: 6446-6450, 1981.
20. Walsh JW, Zimmer SG, Purdue ML: Role of viruses in the induction of primary intracranial tumors. Neurosurgery 10: 643-662, 1982.
21. Carbone M, Rizzo P, Pass HI: Simian virus 40, poliovaccines, and human tumors: A review of recent developments. Oncogene 15: 1877-1888, 1997.
22. Strickler HD, Rosenberg PS, Devesa GG, Hertel J, Fraumeni JF, Goedert JJ: Contamination of poliovirus vaccines with simian virus 40 (1955-1963) and subsequent cancer rates. JAMA 279: 292-295, 1998.
23. Ries LAG, Kosary CL, Hankey BF, Miller BA, Harras A, Edwards BK (eds): SEER Cancer Statistics Review, 1973-1994, National Cancer Institute. NIH Pub. No. 97-2789, Bethesda, MD, 1997.
24. US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute, Cancer Statistics Branch. NCI SEER Cancer Incidence Public-Use Database, 1973-1994. Produced by Information Management Services, Inc. Bethesda, Maryland.
25. Percy C, Holten VV, Muir C (eds): ICD-O: International Classification of Diseases for Oncology. 2nd edition. World Health Organizatiol, 1990.
26. Cutler SJ, Scotto J, Devesa SS, Connelly RR: Third National Cancer Survey-An overview of available information. J Natl Cancer Inst 53: 1565-1575, 1974.
27. DeVesa SS, Silverman DT: Cancer incidence and mortality trends in the United States: 1935-74. J Natl Cancer Inst 60: 545-571, 1978.
28. Preston-Martin S, Mack WJ: Neoplasms of the nervous system. Schottenfeld D, FMumeni J. (eds): Cancer Epidemiology and Prevention. Oxford University Press: Oxford, 1996. pp 1231-1281.
29. Miller RW, Boice JD, Jr., Curtis RE: Bone cancer. Schottenfeld D, Fraumeni J. (eds). Cancer Epidemiology and Prevention. Oxford University Press: Oxford, 1996. pp 971-999.
30. Roggli VL: Malignant Mesothelioma. Henderson DW, Shilkin KB, Le Langlois SP and Whitaker D (eds).. The Cancer Series, Hemisphere Press: New York, 1992. pp 201-250.
31. DeLuca A, Baldi A, Eposito V, Howard CM, Bagella L, Rizzo P, Caputi M, Pass HI, Giordano GG, Baldi F, Carbone M, Giordano A. The retinoblastoma gene family pRb/p105, p107, pRb2/p130 and simian virus 40-large T-antigen in human mesotheliomas. Nature Medicine 3: 913-916, 1997.
32. Carbone M, Rizzo P, Grimley PM, Procopio A, Mew DJ, Shridhar V, Bartolomeis AD, Esposito V, Giuliano MT, Steinberg SM, Levine AS, Giordano A and Pass HI: Simian virus 40 large T-antigen binds p53 in human mesotheliomas. Nature Medicine 3: 908-912, 1997.
33. Klas GW, Klein G: An old acquaintance resurfaces in human mesothelioma. Nature Medicine 8: 839-840, 1997.